Akebia Therapeutics Inc. (NASDAQ: AKBA) saw its shares drop by 28.17% on Thursday due to a disappointing price offering. The tech-heavy Nasdaq led the market decline, with the S&P 500 and Dow Jones also dipping.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing